Literature DB >> 29685495

IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Mark B Jones1.   

Abstract

ST6Gal1 is a critical sialyltransferase enzyme that controls the addition of α2,6-linked sialic acids to the termini of glycans. Attachment of sialic acids to glycoproteins as a posttranslational modification influences cellular responses, and is a well-known modifier of immune cell behavior. ST6Gal1 activity impacts processes such as: effector functions of immunoglobulin G via Fc sialylation, hematopoietic capacity by hematopoietic stem and progenitor cell surface sialylation, and lymphocyte activation thresholds though CD22 engagement and inhibition of galectins. This review summarizes recent studies that suggest α2,6 sialylation by ST6Gal1 has an immunoregulatory effect on immune reactions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody; B cell; Glycosylation; IgG; Immunoregulation; Leukocytes; Sialylation; T cell

Mesh:

Substances:

Year:  2018        PMID: 29685495      PMCID: PMC6167213          DOI: 10.1016/j.cellimm.2018.03.014

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  115 in total

Review 1.  Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins.

Authors:  Susan L Bellis
Journal:  Biochim Biophys Acta       Date:  2004-05-27

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

Review 3.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

Review 4.  Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

Authors:  Jordan S Orange; Elham M Hossny; Catherine R Weiler; Mark Ballow; Melvin Berger; Francisco A Bonilla; Rebecca Buckley; Javier Chinen; Yehia El-Gamal; Bruce D Mazer; Robert P Nelson; Dhavalkumar D Patel; Elizabeth Secord; Ricardo U Sorensen; Richard L Wasserman; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

5.  Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation.

Authors:  Mehrab Nasirikenari; E V Chandrasekaran; Khushi L Matta; Brahm H Segal; Paul N Bogner; Amit A Lugade; Yasmin Thanavala; James J Lee; Joseph T Y Lau
Journal:  J Leukoc Biol       Date:  2009-12-09       Impact factor: 4.962

6.  Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized Mice.

Authors:  Inessa Schwab; Anja Lux; Falk Nimmerjahn
Journal:  Cell Rep       Date:  2015-10-08       Impact factor: 9.423

Review 7.  Siglecs as positive and negative regulators of the immune system.

Authors:  Paul R Crocker; Pierre Redelinghuys
Journal:  Biochem Soc Trans       Date:  2008-12       Impact factor: 5.407

8.  NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation.

Authors:  Adam W Barb; Lu Meng; Zhongwei Gao; Roy W Johnson; Kelley W Moremen; James H Prestegard
Journal:  Biochemistry       Date:  2012-05-22       Impact factor: 3.162

9.  Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis.

Authors:  Michael J Kemna; Rosina Plomp; Pieter van Paassen; Carolien A M Koeleman; Bas C Jansen; Jan G M C Damoiseaux; Jan Willem Cohen Tervaert; Manfred Wuhrer
Journal:  EBioMedicine       Date:  2017-01-28       Impact factor: 8.143

10.  Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.

Authors:  Yuhsuke Ohmi; Wataru Ise; Akira Harazono; Daisuke Takakura; Hidehiro Fukuyama; Yoshihiro Baba; Masashi Narazaki; Hirofumi Shoda; Nobunori Takahashi; Yuki Ohkawa; Shuting Ji; Fumihiro Sugiyama; Keishi Fujio; Atsushi Kumanogoh; Kazuhiko Yamamoto; Nana Kawasaki; Tomohiro Kurosaki; Yoshimasa Takahashi; Koichi Furukawa
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919

View more
  4 in total

1.  Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation.

Authors:  Xiuxia Zhou; Carol L Kinlough; Rebecca P Hughey; Mingzhu Jin; Hideki Inoue; Emily Etling; Brian D Modena; Naftali Kaminski; Eugene R Bleecker; Deborah A Meyers; Nizar N Jarjour; John B Trudeau; Fernando Holguin; Anuradha Ray; Sally E Wenzel
Journal:  JCI Insight       Date:  2019-03-07

2.  Cosmc is required for T cell persistence in the periphery.

Authors:  Christopher E Cutler; Mark B Jones; Alicia A Cutler; Amanda Mener; Connie M Arthur; Sean R Stowell; Richard D Cummings
Journal:  Glycobiology       Date:  2019-10-21       Impact factor: 4.313

Review 3.  Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases.

Authors:  Danqi Li; Yuchen Lou; Yamin Zhang; Si Liu; Jun Li; Juan Tao
Journal:  Theranostics       Date:  2021-03-13       Impact factor: 11.556

4.  Sialylated human milk oligosaccharides program cognitive development through a non-genomic transmission mode.

Authors:  Jonas Hauser; Edoardo Pisa; Alejandro Arias Vásquez; Flavio Tomasi; Alice Traversa; Valentina Chiodi; Francois-Pierre Martin; Norbert Sprenger; Oksana Lukjancenko; Alix Zollinger; Sylviane Metairon; Nora Schneider; Pascal Steiner; Alberto Martire; Viviana Caputo; Simone Macrì
Journal:  Mol Psychiatry       Date:  2021-03-04       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.